The Phase I Study of SIG001 Antibody on Cancer Therapy.
Clinical trial NCT07486700 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07486700
- Sponsor
- Peking University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-04-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.